AstraZeneca (AZN) News Today → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free Azn Stock Alerts £113.52 +84.00 (+0.75%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAstraZeneca (LON:AZN) Given Hold Rating at Deutsche Bank Aktiengesellschaftamericanbankingnews.com - April 24 at 4:00 AMBrexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challengesmsn.com - April 20 at 10:04 AMI don’t care how much FTSE bosses are paid as long as they make me rich!uk.finance.yahoo.com - April 18 at 4:50 AMAstraZeneca (LON:AZN) Raised to "Hold" at Deutsche Bank Aktiengesellschaftamericanbankingnews.com - April 18 at 1:42 AMAstraZeneca (LON:AZN) Upgraded at Deutsche Bank Aktiengesellschaftmarketbeat.com - April 17 at 9:24 AMAstraZeneca (LON:AZN) Receives "Buy" Rating from Shore Capitalamericanbankingnews.com - April 16 at 3:38 AMAstraZeneca (LON:AZN) Rating Reiterated by Shore Capitalmarketbeat.com - April 15 at 2:41 PMUK Stocks: AstraZeneca (AZN) Assures Dividend Growth Before CEO Pay Votemsn.com - April 11 at 12:18 PMLok’nStore, AstraZeneca, Darktrace, Distil, European Metals, XPS Pensions, Mast Energy – Stocks on the moveuk.investing.com - April 11 at 7:17 AMTrending tickers: Darktrace, AstraZeneca, Persimmon, Bitcoinfinance.yahoo.com - April 11 at 7:17 AMAstraZeneca: Board to Raise Annualised Div by $0.20 to $3.10 Per Shrmarketwatch.com - April 11 at 2:17 AMAstraZeneca (LON:AZN) Reaches New 1-Year Low at $105.92marketbeat.com - April 9 at 6:09 AMAstraZeneca (LON:AZN) Receives "Overweight" Rating from Barclaysmarketbeat.com - April 8 at 1:37 PMAstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumormsn.com - April 8 at 12:19 PMShore Capital Reaffirms "Buy" Rating for AstraZeneca (LON:AZN)marketbeat.com - April 5 at 10:41 AMPharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase IIImsn.com - April 5 at 9:36 AMAstraZeneca (LON:AZN) Given "Overweight" Rating at JPMorgan Chase & Co.marketbeat.com - April 4 at 12:16 PMA Closer Look at AstraZeneca's Options Market Dynamicsbenzinga.com - April 3 at 12:30 PMJapan approves AstraZeneca-Sanofi drug for prevention of RSV disease in infantsmsn.com - March 27 at 7:50 AMAstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchasemsn.com - March 19 at 5:55 AMAstraZeneca To Buy Fusion Pharma For Up To $2.4 Blnnasdaq.com - March 19 at 5:55 AMAZN Apr 2024 72.000 callfinance.yahoo.com - March 16 at 5:51 PMAZN May 2024 67.500 callfinance.yahoo.com - March 14 at 9:07 PMAstraZeneca's (AZN) "Sell" Rating Reiterated at Deutsche Bank Aktiengesellschaftmarketbeat.com - March 12 at 11:15 AMAstraZeneca PLC (LON:AZN) Receives Consensus Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - March 11 at 2:32 AMAZN Apr 2024 60.000 putfinance.yahoo.com - March 5 at 1:35 AMDeutsche Bank Aktiengesellschaft Reaffirms Sell Rating for AstraZeneca (LON:AZN)marketbeat.com - February 27 at 6:01 AMAZN Apr 2024 67.000 callfinance.yahoo.com - February 25 at 11:08 PMAZN Mar 2024 57.000 callfinance.yahoo.com - February 23 at 11:54 PMAZN Mar 2024 68.000 putfinance.yahoo.com - February 23 at 11:54 PMAstraZeneca Stock (NASDAQ:AZN) Insider Tradesbenzinga.com - February 22 at 8:09 AMAstraZeneca Prices $5bln Four Tranche Notes Offeringmarkets.businessinsider.com - February 22 at 8:09 AMGracell Biotechnologies receives shareholder approval for merger with AstraZenecamsn.com - February 20 at 8:33 AMAstraZeneca (LON:AZN) Price Target Cut to GBX 120marketbeat.com - February 20 at 7:32 AMAZN Oct 2024 62.500 putfinance.yahoo.com - February 19 at 7:04 AMAstraZeneca's Tagrisso With Chemotherapy Approved In US To Treat Lung Cancermarkets.businessinsider.com - February 19 at 7:04 AMUK shares muted on receding rate cut bets; AstraZeneca gainsmsn.com - February 19 at 7:04 AMAZN Feb 2024 69.000 callfinance.yahoo.com - February 17 at 1:06 AMAstraZeneca (LON:AZN) Rating Reiterated by Jefferies Financial Groupmarketbeat.com - February 16 at 6:00 AMAstraZeneca PLC (LON:AZN) Given Consensus Rating of "Moderate Buy" by Brokeragesmarketbeat.com - February 15 at 1:36 AMStifel Nicolaus Trims AstraZeneca (LON:AZN) Target Price to GBX 120marketbeat.com - February 12 at 4:55 PMAstraZeneca (LON:AZN) Rating Reiterated by BMO Capital Marketsmarketbeat.com - February 12 at 4:55 PMAnalysts Conflicted on These Healthcare Names: GN Store Nord (GB:0K9P), AstraZeneca (GB:AZN) and Ipsen (GB:0MH6)markets.businessinsider.com - February 11 at 7:30 AMAstraZeneca (LON:AZN) Reaches New 1-Year Low at $9,726.00marketbeat.com - February 8 at 1:11 PMAstraZeneca PLC (LON:AZN) Plans Dividend Increase - GBX 156 Per Sharemarketbeat.com - February 8 at 8:25 AMAstraZeneca's Q4 Earnings: Recognizing The Underrated Gem's Growthseekingalpha.com - February 4 at 10:32 AMU.S. govt. opens bids in Medicare drug price negotiationsmsn.com - February 1 at 1:18 PMSeniors could soon get a big break on drug pricesmsn.com - February 1 at 1:18 PMAstrazeneca (AZN) Stock Moves -0.83%: What You Should Knowfinance.yahoo.com - January 31 at 8:04 PMTake Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Sharesbenzinga.com - January 31 at 10:03 AM Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now AZN Media Mentions By Week AZN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.580.44▲Average Medical News Sentiment AZN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼52▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GSK News Dechra Pharmaceuticals News Haleon News Smith & Nephew News ConvaTec Group News Hikma Pharmaceuticals News HUTCHMED News Indivior News EMIS Group News Genus News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AZN) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
